Methods and reagents for treatment and diagnosis of age-related macular degeneration
Details for Australian Patent Application No. 2006214320 (hide)
International Classifications
Event Publications
13 September 2007 PCT application entered the National Phase
PCT publication WO2006/088950 Priority application(s): WO2006/088950
7 July 2011 Application Accepted
Published as AU-B-2006214320
3 November 2011 Standard Patent Sealed
23 February 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 22 Dec 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
5 July 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 22 Dec 2011
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006214321-CD38 modulated chemotaxis
2006214319-Fused heterocyclic compounds useful as inhibitors of histone deacetylase
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser